These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31341257)

  • 1. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
    Li TF; Hu L; Ma XL; Huang L; Liu XM; Luo XX; Feng WY; Wu CF
    Acta Pharmacol Sin; 2019 Dec; 40(12):1603-1610. PubMed ID: 31341257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
    Xue L; Zhang WW; Ding XL; Zhang JJ; Bao JA; Miao LY
    Am J Med Sci; 2014 Dec; 348(6):448-54. PubMed ID: 25247760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
    Kim MG; Kim IW; Choi B; Han N; Yun HY; Park S; Oh JM
    Ann Pharmacother; 2015 Jun; 49(6):622-30. PubMed ID: 25818517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients.
    Zhou H; Gao Y; Cheng XL; Li ZD
    Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):271-8. PubMed ID: 22446981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance.
    Ling J; Yang XP; Dong LL; Jiang Y; Zou SL; Hu N; Chen R
    J Clin Pharm Ther; 2022 Apr; 47(4):483-492. PubMed ID: 34779003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
    Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
    Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients.
    Zhou Y; Sheng XY; Xu JY; Bi SS; Lu W; Cui YM
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):568-75. PubMed ID: 23611568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.
    Eljebari H; Gaies E; Fradj NB; Jebabli N; Salouage I; Trabelsi S; Lakhal M; Klouz A
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1517-24. PubMed ID: 22527344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients.
    Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL
    Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients.
    Chen B; Zhang W; Gu Z; Li J; Zhang Y; Cai W
    Eur J Clin Pharmacol; 2011 Jun; 67(6):601-12. PubMed ID: 21161198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
    Song J; Kim MG; Choi B; Han NY; Yun HY; Yoon JH; Oh JM
    Ann Pharmacother; 2012 Sep; 46(9):1141-51. PubMed ID: 22947591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial dosage optimisation of cyclosporine in Chinese paediatric patients undergoing allogeneic haematopoietic stem cell transplantation based on population pharmacokinetics: a retrospective study.
    Feng H; Wang X; Zheng W; Liu S; Jiang H; Lin Y; Qiu H; Chan TF; Huang M; Li Y; Mo X; Li J
    BMJ Paediatr Open; 2023 Aug; 7(1):. PubMed ID: 37643815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
    Jacobson PA; Ng J; Green KG; Rogosheske J; Brundage R
    Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation.
    Yang X; Yang S; Sun A; Qiu H; Tang X; Han Y; Wu D
    Clin Transplant; 2018 Apr; 32(4):e13220. PubMed ID: 29493007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing cyclosporine A dose post allogeneic hematopoietic stem cell transplantation in paediatric cancer patients.
    Elnaggar M; Hafez H; Abdallah A; Hamza M; Khalaf MM; El-Haddad A
    J Oncol Pharm Pract; 2024 Sep; 30(6):983-991. PubMed ID: 37528663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
    Schrauder A; Saleh S; Sykora KW; Hoy H; Welte K; Boos J; Hempel G; Grigull L
    Pediatr Transplant; 2009 Jun; 13(4):444-50. PubMed ID: 18482216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of cyclosporine A in pediatric patients with thalassemia undergoing allogeneic hematopoietic stem cell transplantation.
    Cai R; Zhang L; Wu T; Huang Y; Lu J; Huang T; Wu Y; Wu D; Qi J; Niu L; Xiao Y; Chen X; Liu Y; Luo Y; Liu T
    Eur J Clin Pharmacol; 2024 May; 80(5):685-696. PubMed ID: 38329479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.
    Punnett A; Sung L; Price V; Das P; Diezi M; Doyle J; Dupuis LL
    Ther Drug Monit; 2007 Dec; 29(6):750-7. PubMed ID: 18043472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.